Antibody Discovery

A scientist wearing a face mask, safety goggles, and blue gloves is holding a conical flask with an orange cap. The flask contains a pink liquid and some solid particles. In the blurred background of the laboratory, bioanalytical development tools hint at advanced research in absolute bioavailability.

The antibody discovery platform at Pharmaron provides service offerings that include the identification of novel and highly potent monoclonal antibodies with desired properties, antibody engineering and characterization of antibodies. We have established phage display and hybridoma technologies to discover novel antibodies as therapeutics and reagents.

For antibodies stemming from mice, our team is experienced in antibody engineering for humanization, which allows for retaining antibody binding affinity and specificity while eliminating most of the immunogenicity of heterologous antibodies in patients. Various assay platforms have been established to characterize the monoclonal antibodies, including biophysical, biochemical and cellular assays.

A gloved hand holding a laboratory pipette with multiple channels dispenses pink liquid into the wells of a microplate. The environment appears to be a lab setting, evident from the scientific equipment and precise handling, indicative of bioanalytical development in preclinical ADME studies.

Phage Display Approach

  • Human naïve libraries
  • Libraries from immunization with a target antigen
  • Construction of targeted antibody fragment libraries
  • Construction of phage libraries
  • Biopanning and affinity screening
  • Hit confirmation
  • IgG conversion
  • Customized immune library generation using mice, camels, and llama
Gloved hands hold a multi-well plate under a microscope for analysis, part of an antibody discovery process in a laboratory setting.

Hybridoma Approach

  • Animal immunization with proprietary protocols for increased immune responses
  • Multiple immunization approaches to tailor the needs of various targets (DNA, peptide, protein, cell, or combination)
  • Generating hybridoma clones using a highly efficient fusion method
  • Screening of hybridoma cells
  • Sequencing of positive clones
A scientist in a lab coat, mask, and gloves operates equipment in a sterile laboratory environment. He is handling a sample with a pipette, contributing to bioanalytical development. Another scientist in a lab coat works at a bench in the background. Both focus on their research tasks.

Antibody Engineering

  • Antibody humanization: CDR & SDR grafting into corresponding human framework regions, chain replacement and screening of a human whole-IgG library
  • The strategy of antibody maturation: random mutation, site-directed mutagenesis and other mutagenesis methods
  • Utilizing proprietary human antibody databases, electronic modeling, and other techniques to aid of design for humanization
A scientist wearing a lab coat, safety goggles, surgical mask, and blue gloves operates a SEEX IU 500 Plus machine in a laboratory setting. The scientist is intently focused on preclinical ADME studies as they work with the equipment.

Characterization of Antibodies

  • Affinity determination by SPR
    • Protein-protein, protein-polypeptide, protein-small molecule binding affinity determination
    • Binding of antibodies and Fc fusion proteins to Fc receptors
    • Dissociation rate ranking
  • Affinity determination by FACS – FACS measurement of affinity to cell surface proteins
  • Biochemical assays
  • Antigen binding test
    • Protein level assay: SPR, ELISA
    • Cellular level assay: FACS
    • Double binding of bi-valent antibodies (protein-protein, cell-protein, cell-cell)
A person wearing a blue glove operates a laboratory machine with "forteBIO" and "octet" branding, crucial for bioanalytical development. The machine contains black rectangular trays with a grid of wells. A green tray with tubes is also visible. A warning sign advises to keep hands clear of moving parts.

Characterization of Antibodies

  • Competition experiment
  • Ligand and receptor blocking assay (protein or cellular level, using ELISA/FACS)
  • Epitope Binding
  • Signaling (phosphorylation)
  • HTRF/AlphaLISA
    • Intracellular cytokine staining(FACS)
  • Cellular assays
    • Proliferation assay (CFSE/BrdU/CellTiter-Glo®)
    • Cell screening (survival/proliferation, 2D, 3D culture)
    • Cell cycle analysis
    • Detection of cell apoptosis